We are live on ! Find out more
ECTE

ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE

Delisted

ECTE was delisted on the 11th of July, 2016.

Back to rankings

2 hedge funds and large institutions have $2K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

67% less capital invested

Capital invested by funds: $6K → $2K (-$4K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EWM
Edge Wealth Management
New York
+$1K

Top Sellers

Rank Fund Capital Flow
1
Truist Financial
Truist Financial
North Carolina
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
Acrospire Investment Management
Illinois
$1K – – –
EWM
2
Edge Wealth Management
New York
$1K +$1K +100 New
Truist Financial
3
Truist Financial
North Carolina
– -$5K -12,000 Closed

ECTE Hedge Fund Activity: Q4 2016 in Review

2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q4 2016, worth a combined $2K — down 67% from $6K a quarter earlier.

Fund positioning in ECTE was balanced in Q4 2016: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Edge Wealth Management, opening a new position worth an estimated $1K. The largest seller was Truist Financial, exiting entirely with an estimated $5K sold.

  • 2 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $2K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q4 2016, down 67% quarter-over-quarter.
  • 1 fund opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q4 2016 and 1 closed out, a net change of 0 holders.
  • The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q4 2016 was Edge Wealth Management, an estimated $1K added.
  • The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q4 2016 was Truist Financial, an estimated $5K sold.

Based on aggregated 13F filings for Q4 2016.